JPRN-UMIN000037134已完成未知
Intravenous immunoglobulin therapy combined with Vitamins E and C for Kawasaki Disease - VITAMEC study
Fukuoka Children's Hospital Kawasaki disease center0 个研究点目标入组 20 人开始时间: 2019年6月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1years-old 至 6years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Cases after the 9th disease day 2. Cases who is taking vitamins at the onset of Kawasaki disease 3. Cases who have coronaly artery lesion at entry 4. Recurrent or relapsed cases of Kawasaki disease 5. Cases whose cause of fever is other than Kawasaki disease 6. Cases who received immunoglobulin within 90 days before entry 7. Cases with serious underlying diseases 8. Cases taking immunosuppressive drugs such as steroids 9. Cases with other diseases that require oral administration of anticoagulants and antiplatelets 10. Cases with allergies to vitamins 11. Other cases judged by the investigator as inappropriate
研究者
相似试验
已完成
不适用
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disordersISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212
尚未招募
Unknown
Intravenous Immunoglobulin replacement therapy for persistent COVID-19 in patients with B-cell impairment: a multicenter randomized controlled trialCertain infectious and parasitic diseasesKCT0009239Samsung Medical Center58
已完成
不适用
High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation.JPRN-UMIN000003034Hematology, Osaka City University, Graduate School of Meicine14
进行中（未招募）
1 期
Early immunotherapy with intravenous immunoglobulin, cyclophosphamide and methylprednisolone in patients with anti-Hu-associated paraneoplastic sensory neuropathy (NESPA).paraneoplastic sensory neuropathy with anti-Hu antibodiesMedDRA version: 20.0Level: PTClassification code: 10072106Term: Paraneoplastic neurological syndrome Class: 100000004852CTIS2023-506942-22-01Assistance Publique Hopitaux De Paris21
已完成
3 期
Intravenous immunoglobulin therapy for small fiber neuropathy: a randomized, double-blind, placebo-controlled study on efficacy and safety.small fiber neuropathy10034606NL-OMON47574Medisch Universitair Ziekenhuis Maastricht60